Skip to main content

Tweets

Eric Dein @ericdeinmd #RNL2025 Treatment of sclerosing skin conditions: Active inflammation? Sclerotic? Atrophic? Target based on activity, depth of involvement and other disease involvement

Dr. John Cush @RheumNow ( View Tweet )

11 months 2 weeks ago
MD Survey: Who should manage patients with hidradentis supprativa?

Dr. John Cush @RheumNow ( View Tweet )

11 months 2 weeks ago
Full read, comprehensive review of Hidradenitis Supprativa in Lancet Feb 1, 2025 Common assn; DM, IBD, Smoking, Obesity, metabolic syndr, NASH, SpA, RA FDA approved Rx: Adalimumab, Secukinumab, Bimekizumab https://t.co/5Tb8on21E0 https://t.co/BLu6Zaejj5
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
Janet Pope @Janetbirdope #ClinicalPearl Insights into #fibrosing #skin conditions Inflammatory Fibrotic Atrophy We treat the #inflammation but need to determine if lesions are active or not Bx May not discern #dx Heidi Jacobe ⁦ #RNL2025 https://t.co/dG1k4fm4aO https://t.co/5TowCCDiTt
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
TheDaoIndex @KDAO2011 @drcharitydean on emerging public health threats including H5N1 & communicable dz. We need to be monitoring for human to human disease transmissions. There is a high level of concern by large business as they recognize this will affect the supply chain.… https://t.co/T3TZ7LtHQi https://t.co/Ar85A0EcW4
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
That's not my problem - or is it? Multimorbidity in RA RA can look so easy on the television commercials where patients appear young, healthy, and vibrant on the advertised treatment. https://t.co/B7WUiysNSE https://t.co/nczmoIBfOb
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
The POWER of #plaquenil #Hydroxychloroquine works in #rheumatic #diseases by Old answer 👇 Alters liposomal membranes 🤷‍♀️ NEW ANSWER Inhibits TLR signalling 🔥 ⁩ #RNL2025 Mary *Peggy Crow #SLE #systemic #lupus #erythematosus https://t.co/j2YQjVIpcy
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
Eric Dein @ericdeinmd B England 75% of RA pts have multi-morbidity Pts develop multi-morbidity BEFORE the onset of RA Should we have different goals: Prioritize LDA over remission in pts w multimorbidity Collaborate w PCP: one size doesn't fit all, do something better than… https://t.co/RIe7BhSgvJ https://t.co/4dVdR088XF
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
TheDaoIndex @KDAO2011 A practical clinic-based approach to assessing CVD, CA screening, lung disease, infections for rheums by Dr Bryant England who offers us menus.. start by asking about symptoms. #RNL2025 https://t.co/AcQDJS870I https://t.co/UCyDOF2GRZ
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
Adela Castro @AdelaCastro222 Multimorbidity in Rheumatoid Arthritis: -Affects >75% of pts -Reduces quality of life and increases mortality -Highly associated w/ D2T RA -Requires multidisciplinary care teams (PCP, specialists, case management, PT) -Management should start early… https://t.co/Sshm8CUWOA https://t.co/W9dojZT99T
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
Jeffrey Curtis @RADoctor Great talk at #RNL2025 by Dr Una Makris on managing geriatric rheumatology patients. How often do we under-treat #Rheumatoid arthritis patients with advanced therapies because we fall into the trap of ageism? https://t.co/kWLxt15n4X https://t.co/cmLjqigNol
Dr. John Cush @RheumNow ( View Tweet )
11 months 2 weeks ago
Janet Pope @Janetbirdope Dispel the #myth #rheumatoid #arthritis is NOT Just a disease of Young and middle aged Elderly PREVALENT #RA Pts and 👇 INCIDENT Pts in >65yrs is skyrocketing 🚀 Need #Rx goals and equitable #Rx Uma Makris #RNL2025 https://t.co/3IsVKTSEyy

Dr. John Cush @RheumNow ( View Tweet )

11 months 2 weeks ago
×